Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email mava@mava.org.
 

 

Check back regularly for news, coverage, and announcements about MAVA.

  
Latest News:

01/08/2014 – Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical

Oxford Finance LLC today announced that it entered into a term loan agreement with Entellus Medical, Inc. that expanded the original $17 million loan facility to $25 million.

01/07/2014 – Mashable Closes $13.3 Million Led by MAVA Leadership Member Updata Partners, New Markets Ventures

This is the company’s first capital raised since its founding in 2005.

01/07/2014 – Riide Smashes $50K Kickstarter Goal in Less Than 24 Hours

Local startup darling Riide has revolutionized bike riding as we know it today.

01/07/2014 – DragonWave Increases ABL Facility With Comerica to $40M

DragonWave Inc. announced that it has amended its existing revolving credit facilities with Comerica Bank and Export Development Canada.

01/06/2014 – Halozyme Secures Additional $20 Million Term Loan from Oxford Finance and Silicon Valley Bank

Halozyme Therapeutics, Inc. today announced it secured an additional $20 million loan from Oxford Finance and Silicon Valley Bank.

01/03/2014 – FireEye acquires Mandiant in $1bn deal

Mandiant rose to prominence last year after it alleged that a secretive branch of China's military had stolen data from more than 100 global firms.

01/02/2014 – Square 1 Bank Acquires Sand Hill Finance

Square 1 Bank, the premier banking partner to entrepreneurs and the venture capital community, announced that it has acquired substantially all of the assets and hired all employees of Sand Hill Finance, LLC.

12/30/2013 – Acura Pharmaceuticals Secures $10.0 Million of Debt Financing

Acura Pharmaceuticals, Inc. ACUR entered into a Loan and Security Agreement with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million.

12/30/2013 – Amicus Therapeutics Completes Debt Financing of Up to $25 Million

Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has completed a $25 million long-term debt financing with a lending syndicate consisting of MidCap Financial, LLC, Oxford Finance LLC, and Silicon Valley Bank.

12/20/2013 – Boulder Ventures, Crestone start new funds

Boulder Ventures Ltd. has raised $100 million for a new fund, and Crestone Capital Advisors LLC has raised $7 million for two new funds, according to documents filed with the Securities and Exchange Commission.

12345678910111213141516171819202122232425262728293031323334353637383940   4142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127